首页 | 本学科首页   官方微博 | 高级检索  
     


Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China
Authors:Jia Fan  Guang-Shun Yang  Zhi-Ren Fu  Zhi-Hai Peng  Qiang Xia  Chen-Hong Peng  Jian-Ming Qian  Jian Zhou  Yang Xu  Shuang-Jian Qiu  Lin Zhong  Guang-Wen Zhou  Jian-Jun Zhang
Affiliation:1. Liver Cancer Institute, Shanghai Medical School, Zhong Shan Hospital, Fudan University, 136 Yi Xue Yuan Road, 200032, Shanghai, People’s Republic of China
2. Dong Fang Gan Dan Hospital, Shanghai Second Military Medical University, 225 Chang Hai Road, 200438, Shanghai, People’s Republic of China
3. Chang Zheng Hospital, Shanghai Second Military Medical University, 435 Fen Yang Road, 200003, Shanghai, People’s Republic of China
4. Shanghai First Hospital, Medical School of Jiaotong University, 85 Wu Jing Road, 200080, Shanghai, People’s Republic of China
5. Ren Ji Hospital, Medical School of Jiaotong University, 145 Shan Dong Zhong Road, 200001, Shanghai, People’s Republic of China
6. Rui Jing Hospital, Medical School of Jiaotong University, 197 Rui Jing Second Road, 200025, Shanghai, People’s Republic of China
7. Hua Shan Hospital, Shanghai Medical School, Fudan University, 12 Wu Lu Mu Qi Zhong Road, 200040, Shanghai, People’s Republic of China
Abstract:Purpose  To evaluate current selection criteria for patients undergoing liver transplantation (LT) in response to hepatocellular carcinoma (HCC), and to analyze the prognostic factors for successful transplantation. Methods  We evaluated the outcome of 1,078 consecutive patients with HCC from the Shanghai Multi-Center Collaborative LT Group who underwent LT over a 6-year period. Clinicopathologic data for these patients were evaluated. The prognostic significance was assessed using Kaplan–Meier survival estimates and log-rank tests. Multivariate study with Cox’s proportional hazard model was used to evaluate the prognosis-relative aspects. Results  We determined that expansion of Milan criteria to include: a solitary lesion ≤9 cm in diameter, no more than three lesions with the largest ≤5 cm, a total tumor diameter ≤9 cm without macrovascular invasion, lymph node invasion and extrahepatic metastasis (referred to as the “Shanghai criteria”), resulted in overall survival (OS) and disease-free survival (DFS) rates that were similar to the Milan criteria. Multivariate analysis using the Cox proportional hazards regression model showed that the Child-Pugh-Turcotte classification (P = 0.010, 0.000), tumor differentiation (P = 0.001, 0.000), tumor size (P = 0.000, 0.000) and number (P = 0.014, 0.016), macrovascular invasion (P = 0.022, 0.000) and alpha-fetoprotein (AFP) levels (P = 0.031, 0.003) were independent predictors of OS and DFS, while post-LT chemotherapy (OS, P = 0.000) and tumor encapsulation (DFS, P = 0.038) were independent predictors of OS or DFS. Conclusion  Shanghai criteria expanded the current criteria while maintaining similar survival. J. Fan, G.-S. Yang, Z.-R. Fu, Z.-H. Peng, Q. Xia, C.-H. Peng, J.-M. Qian, J. Zhou and Y. Xu contributed equally to this work. This is an original work by all the authors from the Shanghai Multi-center Collaborative Liver Transplantation Group.
Keywords:Hepatocellular carcinoma  Liver transplantation  Criteria  Prognosis
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号